US health official Fauci: Initial study of Moderna vaccine encouraging
|The initial study of Moderna's coronavirus vaccine is encouraging, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, told CNBC on Friday.
"We can build on Remdesivir's success," Dr Fauci added. Earlier in the day, Dr Fauci told CNN that he was cautiously optimistic about Moderna's vaccine.
Market reaction
Wall Street's main indexes recovered modestly from session lows after these comments. As of writing, the Nasdaq Composite was flat on the day while the S&P 500 and the Dow Jones Industrial Average were down 0.25% and 0.5%, respectively.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.